CCL2 and prostate cancer: Lu et al. [45] and Sharma et al. [49] report an association between elevated serum CCL2 levels and poor prognosis in patients with prostate cancer, and Lu et al. [44] report an association between elevated serum CCL2 levels and poor prognosis in patients with nasopharyngeal cancer.